Literature DB >> 15815693

Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons.

S Hummel1, D Schmidt, B Kremeyer, B Herrmann, M Oppermann.   

Abstract

A mutant allele of the chemokine receptor CCR5 gene (CCR5-Delta32), which confers resistance to HIV-1 infection, is believed to have originated from a single mutation event in historic times, and rapidly expanded in Caucasian populations, owing to an unknown selective advantage. Among other candidates, the plague bacillus Yersinia pestis was implicated as a potential source of strong selective pressure on European populations during medieval times. Here, we report amplifications of the CCR5-Delta32 DNA sequence from up to 2900-year-old skeletal remains from different burial sites in central Germany and southern Italy. Furthermore, the allele frequency of CCR5-Delta32 in victims of the 14th century plague pandemic in Lubeck/northern Germany was not different from a historic control group. Our findings indicate that this mutation was prevalent already among prehistoric Europeans. The results also argue against the possibility of plague representing a major selective force that caused rapid increase in CCR5-Delta32 gene frequencies within these populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15815693     DOI: 10.1038/sj.gene.6364172

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  34 in total

1.  A simple method for finding explicit analytic transition densities of diffusion processes with general diploid selection.

Authors:  Yun S Song; Matthias Steinrücken
Journal:  Genetics       Date:  2011-12-29       Impact factor: 4.562

2.  Historic exposure to plague and present-day frequency of CCR5del32 in two isolated island communities of Dalmatia, Croatia.

Authors:  Mladen Smoljanović; Smiljana Ristić; Caroline Hayward
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

Review 3.  Human population structure and the adaptive response to pathogen-induced selection pressures.

Authors:  John Novembre; Eunjung Han
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

4.  Estimation of 2Nes from temporal allele frequency data.

Authors:  Jonathan P Bollback; Thomas L York; Rasmus Nielsen
Journal:  Genetics       Date:  2008-05       Impact factor: 4.562

5.  Polymorphism in chemokine receptor genes and risk of acute myocardial infarction in North Indian population.

Authors:  Neha Singh; Nakul Sinha; Sudeep Kumar; Chandra M Pandey; Suraksha Agrawal
Journal:  Mol Biol Rep       Date:  2011-07-10       Impact factor: 2.316

6.  Detecting and Quantifying Natural Selection at Two Linked Loci from Time Series Data of Allele Frequencies with Forward-in-Time Simulations.

Authors:  Zhangyi He; Xiaoyang Dai; Mark Beaumont; Feng Yu
Journal:  Genetics       Date:  2020-08-21       Impact factor: 4.562

Review 7.  Paleopopulation genetics.

Authors:  Jeffrey D Wall; Montgomery Slatkin
Journal:  Annu Rev Genet       Date:  2012-09-17       Impact factor: 16.830

Review 8.  Chemokine receptor CCR5: from AIDS to atherosclerosis.

Authors:  K L Jones; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

9.  Historic, demographic, and genetic evidence for increased population frequencies of CCR5Delta32 mutation in Croatian Island isolates after lethal 15th century epidemics.

Authors:  Zrinka Biloglav; Lina Zgaga; Mladen Smoljanović; Caroline Hayward; Ozren Polasek; Ivana Kolcić; Veronique Vitart; Tatijana Zemunik; Vesna Boraska; Vesela Torlak; Rosanda Mulić; Darko Ropac; Ivica Grković; Diana Rudan; Smiljana Ristić; Maja Barbalić; Harry Campbell; Alan F Wright; Igor Rudan
Journal:  Croat Med J       Date:  2009-02       Impact factor: 1.351

Review 10.  Genome-wide scans for footprints of natural selection.

Authors:  Taras K Oleksyk; Michael W Smith; Stephen J O'Brien
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-01-12       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.